{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:16:45Z","timestamp":1784913405924,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Stiftelsen Konung Gustaf V:s 80-\u00e5rsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR043727"],"award-info":[{"award-number":["R01 AR043727"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR069572"],"award-info":[{"award-number":["R01 AR069572"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1530-2","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T22:23:27Z","timestamp":1519683807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Uta","family":"Hardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg J.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Svenungsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-5537","authenticated-orcid":false,"given":"Caroline","family":"Gr\u00f6nwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"issue":"9957","key":"1530_CR1","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384(9957):1878\u201388.","journal-title":"Lancet"},{"issue":"5","key":"1530_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","volume":"82","author":"R Cervera","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003;82(5):299\u2013308.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1530_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","volume":"12","author":"DS Pisetsky","year":"2016","unstructured":"Pisetsky DS. Anti-DNA antibodies\u2014quintessential biomarkers of SLE. Nat Rev Rheumatol. 2016;12(2):102\u201310.","journal-title":"Nat Rev Rheumatol"},{"key":"1530_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2016.02.001","volume":"131","author":"N Papac-Milicevic","year":"2016","unstructured":"Papac-Milicevic N, Busch CJ, Binder CJ. Malondialdehyde epitopes as targets of immunity and the implications for atherosclerosis. Adv Immunol. 2016;131:1\u201359.","journal-title":"Adv Immunol"},{"key":"1530_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jprot.2013.02.004","volume":"92","author":"N Zarkovic","year":"2013","unstructured":"Zarkovic N, Cipak A, Jaganjac M, Borovic S, Zarkovic K. Pathophysiological relevance of aldehydic protein modifications. J Proteomics. 2013;92:239\u201347.","journal-title":"J Proteomics"},{"issue":"5","key":"1530_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1172\/JCI36800","volume":"119","author":"MY Chou","year":"2009","unstructured":"Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Backhed F, Miller YI, et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest. 2009;119(5):1335\u201349.","journal-title":"J Clin Invest"},{"key":"1530_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaut.2016.05.014","volume":"73","author":"C Gr\u00f6nwall","year":"2016","unstructured":"Gr\u00f6nwall C, Clancy RM, Getu L, Lloyd KA, Siegel DL, Reed JH, Buyon JP, Silverman GJ. Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity. J Autoimmun. 2016;73:30\u201341.","journal-title":"J Autoimmun"},{"issue":"10","key":"1530_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/intimm\/dxt022","volume":"25","author":"C Wang","year":"2013","unstructured":"Wang C, Turunen SP, Kummu O, Veneskoski M, Lehtimaki J, Nissinen AE, Horkko S. Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques. Int Immunol. 2013;25(10):575\u201387.","journal-title":"Int Immunol"},{"key":"1530_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2012.00066","volume":"3","author":"C Gr\u00f6nwall","year":"2012","unstructured":"Gr\u00f6nwall C, Vas J, Silverman GJ. Protective roles of natural IgM antibodies. Front Immunol. 2012;3:66.","journal-title":"Front Immunol"},{"issue":"5","key":"1530_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrrheum.2013.30","volume":"9","author":"GJ Silverman","year":"2013","unstructured":"Silverman GJ, Vas J, Gr\u00f6nwall C. Protective autoantibodies in the rheumatic diseases: lessons for therapy. Nat Rev Rheumatol. 2013;9(5):291\u2013300.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"1530_CR11","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/ar3193","volume":"12","author":"C Anania","year":"2010","unstructured":"Anania C, Gustafsson T, Hua X, Su J, Vikstr\u00f6m M, de Faire U, Heimburger M, Jogestrand T, Frosteg\u00e5rd J. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus. Arthritis Res Ther. 2010;12(6):R214.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1530_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.clim.2012.01.002","volume":"142","author":"C Gr\u00f6nwall","year":"2012","unstructured":"Gr\u00f6nwall C, Akhter E, Oh C, Burlingame RW, Petri M, Silverman GJ. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin Immunol. 2012;142(3):390\u20138.","journal-title":"Clin Immunol"},{"issue":"1","key":"1530_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2014.03.017","volume":"153","author":"C Gr\u00f6nwall","year":"2014","unstructured":"Gr\u00f6nwall C, Reynolds H, Kim JK, Buyon J, Goldberg JD, Clancy RM, Silverman GJ. Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus. Clin Immunol. 2014;153(1):1\u20137.","journal-title":"Clin Immunol"},{"key":"1530_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2016.04.007","volume":"166-167","author":"M Rahman","year":"2016","unstructured":"Rahman M, Sing S, Golabkesh Z, Fiskesund R, Gustafsson T, Jogestrand T, Frosteg\u00e5rd AG, Hafstrom I, Liu A, Frosteg\u00e5rd J. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms. Clin Immunol. 2016;166-167:27\u201337.","journal-title":"Clin Immunol"},{"issue":"8","key":"1530_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/rheumatology\/ken120","volume":"47","author":"J Su","year":"2008","unstructured":"Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frosteg\u00e5rd J. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology. 2008;47(8):1144\u201350.","journal-title":"Rheumatology"},{"issue":"2","key":"1530_CR16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.4049\/jimmunol.0900948","volume":"183","author":"Y Chen","year":"2009","unstructured":"Chen Y, Khanna S, Goodyear CS, Park YB, Raz E, Thiel S, Gr\u00f6nwall C, Vas J, Boyle DL, Corr M, et al. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol. 2009;183(2):1346\u201359.","journal-title":"J Immunol"},{"issue":"10","key":"1530_CR17","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.4049\/jimmunol.0804191","volume":"182","author":"Y Chen","year":"2009","unstructured":"Chen Y, Park YB, Patel E, Silverman GJ. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol. 2009;182(10):6031\u201343.","journal-title":"J Immunol"},{"issue":"48","key":"1530_CR18","doi-asserted-by":"publisher","first-page":"19745","DOI":"10.1073\/pnas.1211868109","volume":"109","author":"C Gr\u00f6nwall","year":"2012","unstructured":"Gr\u00f6nwall C, Chen Y, Vas J, Khanna S, Thiel S, Corr M, Kono DH, Silverman GJ. MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses. Proc Natl Acad Sci U S A. 2012;109(48):19745\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1530_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","volume":"6","author":"LE Munoz","year":"2010","unstructured":"Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010;6(5):280\u20139.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1530_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/03009740903362511","volume":"39","author":"R Ben Mansour","year":"2010","unstructured":"Ben Mansour R, Lassoued S, Elgaied A, Haddouk S, Marzouk S, Bahloul Z, Masmoudi H, Attia H, Aifa MS, Fakhfakh F. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol. 2010;39(3):247\u201353.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1530_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/art.20780","volume":"52","author":"J Frosteg\u00e5rd","year":"2005","unstructured":"Frosteg\u00e5rd J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, H\u00f6rkk\u00f6 S, Witztum JL. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 2005;52(1):192\u2013200.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1530_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1756-185X.2011.01630.x","volume":"14","author":"SZ Hassan","year":"2011","unstructured":"Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, El-Sorougy IM, Abdou MS. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis. 2011;14(4):325\u201331.","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"1530_CR23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.imbio.2011.04.001","volume":"216","author":"D Shah","year":"2011","unstructured":"Shah D, Wanchu A, Bhatnagar A. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology. 2011;216(9):1010\u20137.","journal-title":"Immunobiology"},{"issue":"7","key":"1530_CR24","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/art.27442","volume":"62","author":"G Wang","year":"2010","unstructured":"Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum. 2010;62(7):2064\u201372.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1530_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271\u20137.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1530_CR26","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"9","key":"1530_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/anr.1780320909","volume":"32","author":"MH Liang","year":"1989","unstructured":"Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989;32(9):1107\u201318.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1530_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363\u20139.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1530_CR29","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","volume":"44","author":"DA Isenberg","year":"2005","unstructured":"Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, D'Cruz D, Griffiths B, Khamashta M, Maddison P, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005;44(7):902\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"24","key":"1530_CR30","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353(24):2550\u20138.","journal-title":"N Engl J Med"},{"issue":"8","key":"1530_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/00365510701397538","volume":"67","author":"AS Jonsson","year":"2007","unstructured":"Jonsson AS, Flodin M, Hansson LO, Larsson A. Estimated glomerular filtration rate (eGFRCystC) from serum cystatin C shows strong agreement with iohexol clearance in patients with low GFR. Scand J Clin Lab Invest. 2007;67(8):801\u20139.","journal-title":"Scand J Clin Lab Invest"},{"key":"1530_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.clim.2017.09.013","volume":"183","author":"C Gr\u00f6nwall","year":"2017","unstructured":"Gr\u00f6nwall C, Hardt U, Gustafsson JT, Elvin K, Jensen-Urstad K, Kvarnstrom M, Grosso G, Ronnelid J, Padykov L, Gunnarsson I, et al. Depressed serum IgM levels in SLE are restricted to defined subgroups. Clin Immunol. 2017;183:304\u201315.","journal-title":"Clin Immunol"},{"issue":"6","key":"1530_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.trsl.2010.07.009","volume":"156","author":"CC Mok","year":"2010","unstructured":"Mok CC, Ho LY, Leung HW, Wong LG. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl Res. 2010;156(6):320\u20135.","journal-title":"Transl Res"},{"key":"1530_CR34","doi-asserted-by":"publisher","first-page":"106904","DOI":"10.1155\/2015\/106904","volume":"2015","author":"G Moroni","year":"2015","unstructured":"Moroni G, Quaglini S, Radice A, Trezzi B, Raffiotta F, Messa P, Sinico RA. The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy. J Immunol Res. 2015;2015:106904.","journal-title":"J Immunol Res"},{"key":"1530_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1177\/0961203316686707","volume":"26","author":"A Checa","year":"2017","unstructured":"Checa A, Idborg H, Zandian A, Sar DG, Surowiec I, Trygg J, Svenungsson E, Jakobsson PJ, Nilsson P, Gunnarsson I, et al. Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study. Lupus. 2017;26:1023\u201333.","journal-title":"Lupus"},{"issue":"8","key":"1530_CR36","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00296-011-1964-1","volume":"32","author":"R Mishra","year":"2012","unstructured":"Mishra R, Singh A, Chandra V, Negi MP, Tripathy BC, Prakash J, Gupta V. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis. Rheumatol Int. 2012;32(8):2377\u201382.","journal-title":"Rheumatol Int"},{"issue":"6","key":"1530_CR37","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3109\/14397595.2014.891495","volume":"24","author":"A Nakajima","year":"2014","unstructured":"Nakajima A, Aoki Y, Shibata Y, Sonobe M, Terajima F, Takahashi H, Saito M, Taniguchi S, Yamada M, Nakagawa K. Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis. Mod Rheumatol. 2014;24(6):926\u201330.","journal-title":"Mod Rheumatol"},{"key":"1530_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.immunol.22.012703.104514","volume":"25","author":"A Marshak-Rothstein","year":"2007","unstructured":"Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol. 2007;25:419\u201341.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1530_CR39","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/hep.28970","volume":"65","author":"CJ Busch","year":"2017","unstructured":"Busch CJ, Hendrikx T, Weismann D, Jackel S, Walenbergh SM, Rendeiro AF, Weisser J, Puhm F, Hladik A, Goderle L, et al. Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice. Hepatology. 2017;65(4):1181\u201395.","journal-title":"Hepatology"},{"issue":"2\u20133","key":"1530_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tox.2011.12.001","volume":"292","author":"G Wang","year":"2012","unstructured":"Wang G, Wang J, Fan X, Ansari GA, Khan MF. Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+\/+ mice. Toxicology. 2012;292(2\u20133):113\u201322.","journal-title":"Toxicology"},{"issue":"1","key":"1530_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.alcohol.2011.09.001","volume":"46","author":"TA Wyatt","year":"2012","unstructured":"Wyatt TA, Kharbanda KK, McCaskill ML, Tuma DJ, Yanov D, DeVasure J, Sisson JH. Malondialdehyde-acetaldehyde-adducted protein inhalation causes lung injury. Alcohol. 2012;46(1):51\u20139.","journal-title":"Alcohol"},{"issue":"1","key":"1530_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2901","volume":"11","author":"N Baumgarth","year":"2011","unstructured":"Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11(1):34\u201346.","journal-title":"Nat Rev Immunol"},{"key":"1530_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fimmu.2016.00138","volume":"7","author":"AF Popi","year":"2016","unstructured":"Popi AF, Longo-Maugeri IM, Mariano M. An overview of B-1 cells as antigen-presenting cells. Front Immunol. 2016;7:138.","journal-title":"Front Immunol"},{"issue":"3","key":"1530_CR44","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.4049\/jimmunol.1501843","volume":"196","author":"TD Quach","year":"2016","unstructured":"Quach TD, Rodriguez-Zhurbenko N, Hopkins TJ, Guo X, Hernandez AM, Li W, Rothstein TL. Distinctions among circulating antibody-secreting cell populations, including B-1 cells, in human adult peripheral blood. J Immunol. 2016;196(3):1060\u20139.","journal-title":"J Immunol"},{"key":"1530_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2017.06.004","volume":"84","author":"C Gr\u00f6nwall","year":"2017","unstructured":"Gr\u00f6nwall C, Amara K, Hardt U, Krishnamurthy A, Steen J, Engstr\u00f6m M, Sun M, Ytterberg AJ, Zubarev RA, Scheel-Toellner D, et al. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis. J Autoimmun. 2017;84:29\u201345.","journal-title":"J Autoimmun"},{"issue":"Suppl 11","key":"1530_CR46","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1002\/acr.20572","volume":"63","author":"J Romero-Diaz","year":"2011","unstructured":"Romero-Diaz J, Isenberg D, Ramsey-Goldman R. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index (SDI). Arthritis Care Res. 2011;63(Suppl 11):S37\u201346.","journal-title":"Arthritis Care Res"},{"key":"1530_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13075-015-0896-7","volume":"18","author":"MJ Lewis","year":"2016","unstructured":"Lewis MJ, Vyse S, Shields AM, Zou L, Khamashta M, Gordon PA, Pitzalis C, Vyse TJ, D'Cruz DP. Improved monitoring of clinical response in systemic lupus erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1. Arthritis Res Ther. 2016;18:5.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1530_CR48","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1002\/art.38573","volume":"66","author":"ME Munroe","year":"2014","unstructured":"Munroe ME, Vista ES, Guthridge JM, Thompson LF, Merrill JT, James JA. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare. Arthritis Rheumatol. 2014;66(7):1888\u201399.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1530_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0961203316646463","volume":"26","author":"FM Santos","year":"2017","unstructured":"Santos FM, Telles RW, Lanna CC, Teixeira AL Jr, Miranda AS, Rocha NP, Ribeiro AL. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus. Lupus. 2017;26(1):10\u20136.","journal-title":"Lupus"},{"key":"1530_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/03009742.2016.1231339","volume":"46","author":"I Parodis","year":"2016","unstructured":"Parodis I, Ding H, Zickert A, Arnaud L, Larsson A, Svenungsson E, Mohan C, Gunnarsson I. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis. Scand J Rheumatol. 2016;46:263\u201372.","journal-title":"Scand J Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1530-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:32:46Z","timestamp":1719847966000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1530-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1530"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1530-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"31 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee at Karolinska University Hospital and all study subjects provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"36"}}